Corporate Social Responsibility
Genomics for good
We are driven by the power of genomics to positively impact the world and shape a more sustainable and equitable future for all.
Genomics for good
We are driven by the power of genomics to positively impact the world and shape a more sustainable and equitable future for all.
By embedding our CSR strategy into our business, we are driving positive stakeholder impact and long-term shareholder value
Innovating at the intersection of biology, technology, and health, Illumina is advancing genomics for good to create a healthier, more sustainable, and more equitable future for all. Our CSR strategy promotes the sustainable stewardship of our business by focusing on four key pillars:
2022 Corporate Social Responsibility Report
Learn about the progress we have made to shape a more sustainable and equitable future for all.
Environmental, Social, and Governance Hub
Read our Environmental, Social, and Governance policies, download past reports, and review our data.
Read our latest CSR news
2030 Targets
2 billion
covered lives by 2026
Reach > 25,000
medical education learners annually
5 million
STEM learners reached
Increase
gender representation in global leadership
Maintain
zero net pay gap
Increase
underrepresented minorities in US workforce and leadership
100%
renewable electricity
Net Zero
carbon emissions by 2050
(46% reduction by 2030)
75%
reduction in packaging
100%
strategic suppliers committed to reducing their environmental footprint
20%
spend with diverse suppliers (US)
Achieve
top industry CSR/ESG ratings